Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Theanine, [gamma]-aminobutyric acid and anthocyanin containing composition for relieving visual fatigue

A technology for relieving visual fatigue and GABA, applied in the field of medicine and health, can solve problems such as memory loss, inattention, and ineffective improvement of local eye symptoms, and achieve the effect of improving mental and nervous symptoms and broad market prospects

Inactive Publication Date: 2018-07-27
成都图径生物科技有限公司
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, the products on the market to improve visual fatigue usually only target blue light damage itself, and have no obvious improvement effect on local eye symptoms, and cannot solve other symptoms caused by different degrees of visual fatigue, such as inattention, memory loss, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Theanine, [gamma]-aminobutyric acid and anthocyanin containing composition for relieving visual fatigue
  • Theanine, [gamma]-aminobutyric acid and anthocyanin containing composition for relieving visual fatigue
  • Theanine, [gamma]-aminobutyric acid and anthocyanin containing composition for relieving visual fatigue

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] The preparation of embodiment 1 composition of the present invention

[0033] Raw material weight ratio: 200-400 parts of theanine, 100-300 parts of γ-aminobutyric acid, 100-200 parts of anthocyanin, 100-400 parts of DHA, 5-15 parts of lutein ester, (3R, 3 1 to 5 parts of 'R)-dihydroxy-β-carotene.

[0034] Preparation:

[0035] 1. Mix theanine, γ-aminobutyric acid, anthocyanin, DHA, (3R,3'R)-dihydroxy-β-carotene and lutein ester in a weight ratio, then add syrup and stir evenly.

[0036] 2. After the injection mold is cooled and formed, it can be made into hard, toffee, sandwich, crispy, burnt (toffee), inflated, gel, gum base, compressed, liquid, diaphragm, fancy and other candies as required types, as well as chocolate and chocolate products, cocoa butter substitute chocolate and cocoa butter substitute chocolate products, jelly (juice type, pulp type, fruity type, milk type, etc.) and other confectionary products.

Embodiment 2

[0037] The preparation of embodiment 2 compositions of the present invention

[0038] Raw material weight ratio: 200-400 parts of theanine, 100-300 parts of γ-aminobutyric acid, 100-200 parts of anthocyanin, 100-400 parts of DHA, (3R,3'R)-dihydroxy-β- 1-10 parts of carotene, 1-25 parts of lutein ester.

[0039] Preparation method: select the raw materials of theanine, γ-aminobutyric acid, anthocyanin, (3R,3'R)-dihydroxy-β-carotene, and lutein ester to mix, add the required treated water and 30- 45 The liquid milk is fully stirred, dissolved, and homogenized, and the homogenization pressure is 25Mpa, and then subjected to ultra-high temperature sterilization, aseptic packaging, and put into storage after passing the inspection.

Embodiment 3

[0040] The preparation of embodiment 3 compositions of the present invention

[0041]Raw material weight ratio: 200-600 parts of theanine, 100-400 parts of γ-aminobutyric acid, 50-200 parts of anthocyanin, 100-600 parts of DHA, (3R,3'R)-dihydroxy-β- 0.2-10 parts of carotene, 0.6-25 parts of lutein ester.

[0042] Preparation method: select theanine, γ-aminobutyric acid, anthocyanin, DHA, (3R,3'R)-dihydroxy-β-carotene, lutein ester, stir evenly, sterilize with ozone, fill, It can be taken directly or added to other foods as a functional auxiliary material.

[0043] The beneficial effects of the present invention are demonstrated by test examples below.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a theanine, [gamma]-aminobutyric acid and anthocyanin containing composition for relieving visual fatigue, and belongs to the field of medical health. According to the composition for relieving the visual fatigue provided by the invention, active ingredients include theanine, [gamma]-aminobutyric acid and anthocyanin. Based upon trial results on people, it is indicated that the composition not only can relieve local symptoms of eyes having the visual fatigue but also can obviously improve psychoneural symptoms, such as attention-deficit disorder, memory loss and the like, caused by visual fatigue of different degrees; and the composition is obvious in effect of relieving the visual fatigue and has a broad market prospect.

Description

technical field [0001] The invention relates to a composition for relieving visual fatigue containing theanine, gamma-aminobutyric acid and anthocyanin, and belongs to the field of medicine and health. Background technique [0002] Visual fatigue, also known as eye fatigue, is a syndrome based on the subjective symptoms of the patient's eyes, eye or systemic organic factors and mental (psychological) factors. It is not an independent eye disease, so it is often called eye fatigue syndrome. (Refer to: 1. Li Fengming. Chinese Ophthalmology [M]. Beijing: People's Health Publishing House, 2006, 7-8; 2. Qu Hongying et al. Research progress on etiology and treatment of visual fatigue [J]. Chinese Medicine Ophthalmology Journal, 2003, 14(1): 59-61). Mild visual fatigue will cause eye symptoms such as eye soreness and swelling after using the eyes, and will recover soon after rest; moderate visual fatigue will have obvious eye symptoms, which will affect study and work; severe visu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/198A61K31/352A61K31/197A61K31/202A61K31/047A61K31/22A61K31/07A61P27/02A61P25/28A61P25/00A61P25/22A61P25/20A23L33/175A23L33/105A23L33/10A23L33/115
CPCA23L33/10A23L33/105A23L33/115A23L33/175A23V2002/00A61K31/047A61K31/07A61K31/197A61K31/198A61K31/202A61K31/22A61K31/352A61K2300/00A23V2200/30A23V2250/038A23V2250/0646A23V2250/1882A23V2250/2104
Inventor 魏巍
Owner 成都图径生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products